America’s opioid epidemic: Part 5 — the future of safer opioid use
The opioid crisis is staggering, but steps are being taken in the right direction. What will tomorrow hold for safer opioid use?
July 12, 2016 | Cathy Starner, PharmD, BCPS
America’s opioid epidemic: Part 4 — fighting overuse through legislation, advocacy and political action
Solving the opioid crisis goes beyond the private sector. To drive meaningful change, health care, government and industry groups all have to work together.
July 8, 2016 | Cathy Starner
America’s opioid epidemic: Part 3 — strategies for curbing abuse
Combating the opioid crisis requires a full set of tools — and proof that they work. See how the research stacks up.
July 5, 2016 | Cathy Starner
America’s opioid epidemic: Part 2 — adding it up
To address the problem, we first have to gauge it. Prime’s researchers have worked to pinpoint who’s at highest risk for harm from controlled substances, such as opioids, and how this use potentially impacts the total cost of care.
June 28, 2016 | Cathy Starner
America’s opioid epidemic: Part 1 — diagnosing the problem
Opioid drugs are killing more Americans than ever. Every health care stakeholder must take action. Prime explores the ins and outs of opioid overuse and management in our latest five-part series.
April 29, 2016 | Kevin Bowen
4.5-year study finds diabetes and related drug costs surging
By 2050, as many as 1 in 3 adults in the United States will have diabetes. Coupled with drug price inflation, rising diabetic drug use has led to mounting costs for plan sponsors. To help measure the impact of rising use and costs, our team dove deep into Prime’s data to study diabetes prevalence, incidence and drug therapy.
April 28, 2016 | Kevin Bowen
What can drug therapy tell us about severe hypoglycemic events?
Hypoglycemia can trigger serious symptoms, such as impaired vision, seizures and unconsciousness.
To better understand if and how emergency department visits for hypoglycemia are related to diabetes types and drug regimens, our team studied data from nearly 4 million members.
April 26, 2016 | Cathy Starner
Can alerts at the pharmacy counter help curb opioid use?
Opioid misuse has emerged as an epidemic. The Centers for Medicare and Medicaid Services has implemented an opioid overutilization monitoring system. But is it enough? My team and I recently explored whether additional opportunity to curb opioid use existed.
April 22, 2016 | Cathy Starner
Taken together, triple threat drugs prove dangerous — and costly
As administrators of prescription drug programs, pharmacy benefit managers can play an important role in helping prevent opioid overdose deaths. Prime reviewed data from 15 million members to study the impact of “Triple Threat” drug use.